Mark Lisowski
About Mark Lisowski
Mark Lisowski is the Principal Clinical Product Risk Specialist at Boston Scientific, with extensive experience in scientific research and product development.
Title
Mark Lisowski holds the position of Principal Clinical Product Risk Specialist at Boston Scientific. He has been in this role since 2019.
Current Role at Boston Scientific
Mark Lisowski currently works as the Principal Clinical Product Risk Specialist at Boston Scientific in Arden Hills, MN. In this role, he participates in cross-functional development teams as the clinical representative to support product development and commercialization. He is responsible for writing Clinical Evaluation Reports and evaluating scientific literature and clinical trial data.
Previous Roles and Experience
Mark Lisowski has a diverse background with extensive experience in multiple roles. Before his current position, he was a Principal Preclinical Research Associate at Boston Scientific’s Research and Technology Center from 2015 to 2018. He also worked at Surpass, Inc as an Associate Scientific Director (2014-2015) and as Senior Scientist / Operations Manager (2010-2014). Additionally, he held the position of Senior Study Director at WuXi AppTec in 2008 and held other scientific roles at Surpass, Inc and Boston Scientific earlier in his career.
Educational Background
Mark Lisowski studied at the University of Minnesota Duluth, where he earned a Bachelor's Degree in Cell Biology and Anatomy. He completed his studies from 1988 to 1992.
Collaboration and Responsibilities
In his role at Boston Scientific, Mark Lisowski collaborates with various departments including Sales and Marketing, R&D, Regulatory Affairs, Quality, and Medical Safety to drive project deliverables. His responsibilities include reviewing hazard analyses, risk documents, and product complaint data. He is involved in analyzing scientific data and collaborating on risk assessment and product labeling.